1,104
Views
11
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: Anal cancer

Efficacy and safety of helical tomotherapy with daily image guidance in anal canal cancer patients

, , , , , , , , , & show all
Pages 767-773 | Received 17 Sep 2015, Accepted 09 Nov 2015, Published online: 01 Apr 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yi Bin Pan, Yasuko Maeda, Ana Wilson, Rob Glynne-Jones & Carolynne J. Vaizey. (2018) Late gastrointestinal toxicity after radiotherapy for anal cancer: a systematic literature review. Acta Oncologica 57:11, pages 1427-1437.
Read now
Jon Espen Dale, Sigrun Sebjørnsen, Sabine Leh, Cornelia Rösler, Stein Aaserud, Bjørn Møller, Øystein Fluge, Christian Erichsen, Saied Nadipour, Hartwig Kørner, Frank Pfeffer & Olav Dahl. (2017) Multimodal therapy is feasible in elderly anal cancer patients. Acta Oncologica 56:1, pages 81-87.
Read now

Articles from other publishers (9)

N. Giraud, M. Bacci & V. Vendrely. (2020) Chimioradiothérapie des carcinomes épidermoïdes du canal anal : traitement standard et enjeux actuels. Côlon & Rectum 14:3, pages 118-126.
Crossref
Elahe Bavandpour, Maryam Bavandpour, Zahra Karimi, Mehrdad Payandeh, Ebrahim Shakiba & Maliheh Dayani. (2019) Safety and Efficacy of Tomotherapy for Lung Cancer Compared to Other Radiotherapy Techniques: A Systematic Review. Health Technology Assessment in Action 2:1.
Crossref
Xiao-Cang Ren, Yue-E Liu, Jing Li & Qiang Lin. (2019) Progress in image-guided radiotherapy for the treatment of non-small cell lung cancer. World Journal of Radiology 11:3, pages 46-54.
Crossref
Pierfrancesco Franco, Berardino De Bari, Francesca Arcadipane, Alexis Lepinoy, Manuela Ceccarelli, Gabriella Furfaro, Massimiliano Mistrangelo, Paola Cassoni, Martina Valgiusti, Alessandro Passardi, Andrea Casadei Gardini, Elisabetta Trino, Stefania Martini, Giuseppe Carlo Iorio, Andrea Evangelista, Umberto Ricardi & Gilles Créhange. (2018) Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study. Radiation Oncology 13:1.
Crossref
Guillaume Klausner, Eivind Blais, Raphaël Jumeau, Julian Biau, Mailys de Meric de Bellefon, Mahmut Ozsahin, Thomas Zilli, Raymond Miralbell, Juliette Thariat & Idriss Troussier. (2018) Management of locally advanced anal canal carcinoma with intensity-modulated radiotherapy and concurrent chemotherapy. Medical Oncology 35:10.
Crossref
Christopher M. Jones, Richard Adams, Amy Downing, Rob Glynne-Jones, Mark Harrison, Maria Hawkins, David Sebag-Montefiore, Duncan C. Gilbert & Rebecca Muirhead. (2018) Toxicity, Tolerability, and Compliance of Concurrent Capecitabine or 5-Fluorouracil in Radical Management of Anal Cancer With Single-dose Mitomycin-C and Intensity Modulated Radiation Therapy: Evaluation of a National Cohort. International Journal of Radiation Oncology*Biology*Physics 101:5, pages 1202-1211.
Crossref
Francesca Arcadipane, Pierfrancesco Franco, Manuela Ceccarelli, Gabriella Furfaro, Nadia Rondi, Elisabetta Trino, Stefania Martini, Giuseppe Carlo Iorio, Massimiliano Mistrangelo, Paola Cassoni, Patrizia Racca, Mario Morino & Umberto Ricardi. (2018) Image-guided IMRT with simultaneous integrated boost as per RTOG 0529 for the treatment of anal cancer. Asia-Pacific Journal of Clinical Oncology 14:3, pages 217-223.
Crossref
Yao-Ching Wang, Chia‑Chin Li & Chun-Ru Chien. (2018) Effectiveness of tomotherapy v s linear accelerator image-guided intensity-modulated radiotherapy for localized pharyngeal cancer treated with definitive concurrent chemoradiotherapy: a Taiwanese population-based propensity score-matched analysis . The British Journal of Radiology, pages 20170947.
Crossref
Berardino De Bari, Laëtitia Lestrade, Alessandra Franzetti-Pellanda, Raphael Jumeau, Maira Biggiogero, Melpomeni Kountouri, Oscar Matzinger, Raymond Miralbell, Jean Bourhis, Mahmut Ozsahin & Thomas Zilli. (2018) Modern intensity-modulated radiotherapy with image guidance allows low toxicity rates and good local control in chemoradiotherapy for anal cancer patients. Journal of Cancer Research and Clinical Oncology 144:4, pages 781-789.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.